Gainers
Don’t forget to check out our premarket coverage here .
Losers
- OptimizeRx Corporation (NASDAQ:OPRX) shares fell 21.8% to $17.40 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
- BigBear.ai Holdings, Inc. (NYSE:BBAI) shares fell 20.4% to $2.18 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
- PLBY Group, Inc. (NASDAQ:PLBY) shares fell 16.5% to $5.82 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results.
- Roblox Corporation (NASDAQ:RBLX) fell 14.4% to $40.52 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results and announced bookings were 4% down year over year.
- Evotec SE (NASDAQ:EVO) fell 12.4% to $12.35 in pre-market trading. Evotec Biologics and Alpine Immune Sciences expanded partnership for commercial process development of ALPN-303.
- Nextdoor Holdings, Inc. (NASDAQ:KIND) fell 12.2% to $3.16 in pre-market trading after the company reported downbeat Q2 results and issued weak Q3 forecast.
- Immatics N.V. (NASDAQ:IMTX) fell 11% to $11.06 in pre-market trading. Immatics, on Tuesday, reported Q2 sales of $17.9 million.
- Coinbase Global, Inc. (NASDAQ:COIN) fell 7.8% to $80.87 in pre-market trading after the company reported a wider-than-expected loss for its second quarter and also shared an updated full year guidance.
- Vertex Energy, Inc. (NASDAQ:VTNR) fell 7.6% to $7.21 in pre-market trading. HC Wainwright & Co. maintained Vertex Energy with a Buy and lowered the price target from $25 to $15. Vertex Energy shares dipped 44% on Tuesday after the company reported worse-than-expected Q2 EPS.
- AbCellera Biologics Inc. (NASDAQ:ABCL) fell 7.3% to $10.29 in pre-market trading following downbeat Q2 sales.
- Alcon Inc. (NYSE:ALC) shares fell 5.6% to $71.21 in pre-market trading after the company reported Q2 results.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
